Primary Breast Lymphoma: A Case Report of a Common Tumor in an Uncommon Location.
Primary breast lymphoma (PBL) is a rare malignant lymphoid neoplasm limited to the breast, accounting for about 0.15% of all malignant breast tumors and 1.7% to 2.2% of extra-nodal lymphomas. PBL must be distinguished from conventional breast carcinomas due to different therapeutic approaches. A 25-...
| Publicado en: | Clinical Pathology pp. 1 - 5 |
|---|---|
| Autores principales: | , , , , |
| Formato: | case study diagnostic images pictorial Journal Article |
| Publicado: |
Sage Publications Inc.
9/6/2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=179505703&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 179505703 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 2632010X M8A9 jtl: Clinical Pathology issn: 2632010X maglogo: Y pubinfo: dt: 9/6/2024 pid: 344 pub: Sage Publications Inc. place: Thousand Oaks, California artinfo: ui: 179505703 179505703 179505703 10.1177/2632010X241276947 179505703 ppf: 1 ppct: 4 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Primary Breast Lymphoma: A Case Report of a Common Tumor in an Uncommon Location. aug: au: Mremi, Alex Chipongo, Hilary Urassa, Ellyagape Mkwizu, Elifuraha Lodhia, Jay affil: Department of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania sug: subj: Breast Neoplasms Diagnosis Lymphoma, B-Cell Diagnosis Breast Neoplasms Therapy Lymphoma, B-Cell Therapy Female Adult Breast Pathology Breast Examination Lymphatic Diseases Lactate Dehydrogenase Blood Biopsy Histocytochemistry Immunohistochemistry Antigens, Tumor Blood Chemotherapy, Cancer Breast Neoplasms Prognosis Lymphoma, B-Cell Prognosis Rituximab Therapeutic Use Antineoplastic Agents Therapeutic Use Radiotherapy Adult: 19-44 years Female ab: Primary breast lymphoma (PBL) is a rare malignant lymphoid neoplasm limited to the breast, accounting for about 0.15% of all malignant breast tumors and 1.7% to 2.2% of extra-nodal lymphomas. PBL must be distinguished from conventional breast carcinomas due to different therapeutic approaches. A 25-year-old female presented with a left breast mass. Histopathology and immunohistochemical tests confirmed the diagnosis of diffuse large B-cell lymphoma (DLBCL). She had no similar lesions elsewhere in the body. She received 1 cycle of R-CHOP chemotherapy but absconded from the treatment and succumbed afterward while at home. Recent developments in DLBCL treatment have greatly improved patient outcomes by incorporating targeted medicines like rituximab, increased chemotherapy regimens, new drugs, and individualized treatment techniques. PBL appears to have a worse prognosis; thus, delay or abscondment from treatment is of serious concern when it comes to improving the prognosis of patients with PBL. pubtype: Academic Journal doctype: case study diagnostic images pictorial Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|